Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study

Detalles Bibliográficos
Autores principales: de Gruijl, Tanja, Santegoeds, Saskia, van Wetering, Sandra, Singh, Satwinder Kaur, Hall, Anthony, van de Loosdrecht, Arjan A, Kruisbeek, Ada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991268/
http://dx.doi.org/10.1186/2051-1426-1-S1-P205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991268/
http://dx.doi.org/10.1186/2051-1426-1-S1-P205

Ejemplares similares